Chinese Health Investigation of Nurse Aging

November 27, 2013 updated by: Bai Wen-Pei
A follow-up intervention for the climacteric symptoms of nurses in Peking

Study Overview

Status

Unknown

Conditions

Detailed Description

As we all know,hormone replacement therapy (HRT) is the main therapy to climacteric symptoms.But HRT has also some disadvantages including breast cancer,cardiovascular disease and so on, especially long period of HRT. It makes us to find the non-hormone therapy. So we want to investigate the exercise on the effect of climacteric symptoms.Doing exercise is helpful for avoiding and treating many disease,including climacteric symptoms.In our previous research,we found that playing exercise can treat moderate climacteric symptoms.

Study Type

Observational

Enrollment (Anticipated)

2

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

About 2000 nurese aged 40-55 living in peking will be investigated.We will measure the symptoms of perimenopausal syndrome by kupperman index、HRQOL（health -related quality of life) to evaluate the severity of menopausal syndrome and quality of life.We choose nurses whose KMI is above 15 and divided them into intervention group and control group.In intervention group,we give them health education and exercise intervention.

Description

Inclusion Criteria:

  • they are nurse ,aged40-55, lived in peking ,who are among perimenopausal women.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the number of KMI
Time Frame: up to 2 years
KMI is the short of Kupperman index, which is a questionnaire that assesses the severity of women's climacteric symptoms.
up to 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
blood lipid
Time Frame: up to 2 years
blood lipid is an index to measure the effect of exercise.
up to 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Bai Wen-Pei

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2008

Primary Completion (Anticipated)

September 1, 2015

Study Completion (Anticipated)

September 1, 2016

Study Registration Dates

First Submitted

November 20, 2013

First Submitted That Met QC Criteria

November 27, 2013

First Posted (Estimate)

December 4, 2013

Study Record Updates

Last Update Posted (Estimate)

December 4, 2013

Last Update Submitted That Met QC Criteria

November 27, 2013

Last Verified

November 1, 2013

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 83573214

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Menopausal Syndrome

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe